Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease

Gene Therapy

Volumn 9, Issue 3, 2002, Pages 201-207

  Maury, S ^a   Litvinova, E ^a   Boyer, O ^a   Benard, L ^a   Bruel, S ^a   Klatzmann, D ^a   Cohen, J L ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CFSE; Cyclosporin A; Graft versus host disease; Hematopoietic stem cell transplantation; Herpes simplex type 1 thymidine kinase; Suicide gene therapy

Indexed keywords

CYCLOSPORIN A; CYTOSTATIC AGENT; GANCICLOVIR; THYMIDINE KINASE;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CONTROLLED STUDY; CYTOLYSIS; DONOR; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX VIRUS 1; IN VIVO STUDY; LETHALITY; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; SUICIDE GENE THERAPY; SURVIVAL; T LYMPHOCYTE;

ANIMALIA; HUMAN HERPESVIRUS 1; MURINAE; SIMPLEXVIRUS;

EID: 0036187792     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301637     Document Type: Article

References (29)

1. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial
2. Acute graft-versus-host disease
3. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation
4. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
5. Successful allogeneic transplantation of T cell-depleted bone marrow from closely HLA-matched unrelated donors
6. Graft-versus-leukemia reactions after bone marrow transplantation
7. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T cell depletion
8. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T cell depletion after bone marrow transplantation?
9. Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes
10. Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene
11. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
12. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T cell-depleted allogeneic marrow graft
13. Adoptive immunotherapy for leukemia: Donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103
14. Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR
15. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2
16. Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes
17. Suicide gene-mediated modulation of graft-versus-host disease
18. The effect of graft-versus-host disease on T cell production and homeostasis
19. Suicide gene therapy of graft-versus-host disease: Immune reconstitution with transplanted mature T cells
20. Immunological defects after suicide gene therapy of experimental graft-versus-host disease
21. Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease
22. Biological effects of cyclosporin A: A new antilymphocytic agent
23. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation
24. Combination therapy with a CD4-CDR3 peptide analog and cyclosporin A to prevent graft-versus-host disease in a MHC-haploidentical bone marrow transplantation model
25. Use of cyclosporin A in allogeneic bone marrow transplantation in the rat
26. Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: Apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression
27. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
28. Regression of metastatic renal cell carcinoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation
29. Malignancies after hematopoietic stem cell transplantation: Many questions, some answers